{"disease":{"id":"hematologic-cancer","name":"hematologic cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01287000","title":"Gulf Long-Term Follow-Up Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":32658,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT04466059","title":"Better Leukemia Diagnostics Through AI (BELUGA)","phase":"","overall_status":"RECRUITING","enrollment_count":25000,"lead_sponsor_name":"Munich Leukemia Laboratory","has_results":false},{"nct_id":"NCT05142033","title":"Avera Cancer Sequencing and Analytics Protocol (ASAP)","phase":"","overall_status":"RECRUITING","enrollment_count":25000,"lead_sponsor_name":"Avera McKennan Hospital & University Health Center","has_results":false},{"nct_id":"NCT02586389","title":"Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Sequenom, Inc.","has_results":false},{"nct_id":"NCT06116032","title":"Immune Profiling for Cancer Immunotherapy Response","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Dartmouth-Hitchcock Medical Center","has_results":false},{"nct_id":"NCT05600933","title":"Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1200,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06503380","title":"Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06296368","title":"DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics","phase":"NA","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT03222258","title":"Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":444,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT02158858","title":"A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":336,"lead_sponsor_name":"Constellation Pharmaceuticals","has_results":false},{"nct_id":"NCT03219268","title":"A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":277,"lead_sponsor_name":"MacroGenics","has_results":false},{"nct_id":"NCT02304809","title":"Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":216,"lead_sponsor_name":"UNICANCER","has_results":false},{"nct_id":"NCT05375643","title":"SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)","phase":"NA","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Nadine McCleary, MD, MPH","has_results":false},{"nct_id":"NCT05175508","title":"Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT07474051","title":"Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":178,"lead_sponsor_name":"AvenCell Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05784870","title":"A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":168,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT05481502","title":"An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Gustave Roussy, Cancer Campus, Grand Paris","has_results":false},{"nct_id":"NCT03218254","title":"MethylphenIdate for Fatigue in Haematological Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Henrik Frederiksen","has_results":false},{"nct_id":"NCT05384288","title":"Response to Influenza Vaccination in Pediatric Oncology Patients","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT07286539","title":"Precision Physical Exercise for Personalized Onco-Hematology.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Salamanca","has_results":false},{"nct_id":"NCT03512340","title":"Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Surface Oncology","has_results":false},{"nct_id":"NCT04235153","title":"CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients","phase":"","overall_status":"COMPLETED","enrollment_count":127,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07409662","title":"Coverage and Cost of Care Links- Telehealth","phase":"NA","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Jean Edward","has_results":false},{"nct_id":"NCT05486273","title":"Evaluation of the Impact of Sports-inspired Onco-coaching on Health-related Quality's Life of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells","phase":"NA","overall_status":"UNKNOWN","enrollment_count":108,"lead_sponsor_name":"Institut Paoli-Calmettes","has_results":false},{"nct_id":"NCT06377059","title":"Early Detection of Complications During Immunotherapy for Haematological Malignancy","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05465577","title":"Coverage and Cost-of-Care (CC) Links- Financial Navigation Program","phase":"NA","overall_status":"COMPLETED","enrollment_count":94,"lead_sponsor_name":"Jean Edward","has_results":false},{"nct_id":"NCT05646576","title":"Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT02223052","title":"Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Celgene","has_results":false},{"nct_id":"NCT06904066","title":"Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":86,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04966156","title":"Cancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMT","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT05099237","title":"Enhanced Monitoring for Better Recovery and Cancer Experience in Greater Manchester","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Manchester University NHS Foundation Trust","has_results":false},{"nct_id":"NCT07251348","title":"Progressive Relaxation and Psychoeducation in Patients With Hematological Malignancies","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":75,"lead_sponsor_name":"Necmettin Erbakan University","has_results":false},{"nct_id":"NCT05147311","title":"Positive Psychology Intervention In HSCT","phase":"NA","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT05715047","title":"Intervention for Fatigue in HCT Recipients","phase":"NA","overall_status":"RECRUITING","enrollment_count":66,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04035447","title":"Symptom Management for YA Cancer Survivors","phase":"NA","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Duke University","has_results":true},{"nct_id":"NCT05690230","title":"Improving Patient Experience: BMBA","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT05493800","title":"Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"MitoImmune Therapeutics","has_results":false},{"nct_id":"NCT05942885","title":"Hypnosis: a Path to Appeasement","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03556748","title":"WB-EMS and Nutrition in Patients With Hematological Malignancies","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University of Erlangen-Nürnberg Medical School","has_results":false},{"nct_id":"NCT06462365","title":"Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Tr1X, Inc.","has_results":false},{"nct_id":"NCT06260111","title":"Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Universidad del Desarrollo","has_results":false},{"nct_id":"NCT07456189","title":"The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT03091933","title":"Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Ciusss de L'Est de l'Île de Montréal","has_results":false},{"nct_id":"NCT03654404","title":"A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT04822974","title":"TORQUETENOVIRUS IN CAR-T THERAPY: PREDICTION OF THE CRS","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Institut Paoli-Calmettes","has_results":false},{"nct_id":"NCT04303091","title":"The Feasibility of a Physical Activity Intervention for Advanced Multiple Myeloma Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Dr. Nicole Culos-Reed","has_results":false},{"nct_id":"NCT03882203","title":"CLAGE Sequential With Flu-Bu Conditioning for Refractory Acute Leukemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT06689332","title":"Improving Quality of Life in Frail, Older Patients with Hematological Cancer Through Geriatric Assessment and Treatment - a Pilot Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Odense University Hospital","has_results":false},{"nct_id":"NCT03955276","title":"An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme)","phase":"","overall_status":"TERMINATED","enrollment_count":13,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT05400122","title":"Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer","phase":"PHASE1","overall_status":"SUSPENDED","enrollment_count":12,"lead_sponsor_name":"David Wald","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}